

An exclusive peptide and longevity membership for the discerning few. Biological optimization through medical-grade oversight and computational precision.
A licensed physician reviews your biomarkers and prescribes a protocol designed for your biology — not one of four lifestyle buckets. Quarterly recalibration as your data changes.
Every prescription is written by a licensed clinician. Every compound is dispensed exclusively by 503A compounding pharmacies — patient-specific, traceable, and regulated. We do not source from research-grade suppliers. Engaged with the FDA's July 2026 PCAC peptide classification proceedings.
Peptide therapy, hormone optimization, and GLP-1 weight loss — under one chart, one physician relationship, one continuous data view.
Standard Opus membership at launch will be $79/month. Founders never pay more.
$39/month, grandfathered for the life of an active membership. Founders never pay the standard rate.
15% off every peptide vial, GLP-1 prescription, and HRT order. Stacks on member pricing.
$50 every month, applied automatically to your next qualifying order. Never expires while active.
~$400 value. Hormone, metabolic, inflammation markers, IGF-1. Drawn at a partner lab in your area.
45-minute video consults with your care team to review labs, adjust protocol, and refine your plan.
Your Founders number is your access. Messages routed ahead of standard members.
Closed-door virtual sessions with the medical advisory team. Quarterly.
See every new compound, protocol, and product launch before the public does.
A digital home for your protocol history, lab trends, recalibration timeline, and member number. One of 500. Permanent.
One free vial of choice on your first qualifying order.
The FDA is convening a PCAC meeting in July 2026 to address the peptide industry's regulatory gray zone. A significant portion of what's sold online today is research-grade, not medical-grade — different sourcing, different oversight, different risk profile.
Opus is built for the regulated future, not the gray present. Every prescription is written by a licensed clinician. Every compound is dispensed exclusively by 503A compounding pharmacies — patient-specific, prescription-bound, state-board regulated, and fully traceable. We do not source from research-grade vendors, peptide retailers, or 503B outsourcing facilities. When the regulations tighten, Opus members keep their care.
GLP-1 weight loss integrated with peptides supporting lean mass preservation, glucose regulation, and metabolic health.
Full HRT protocols (testosterone, thyroid, estrogen) coordinated with growth hormone secretagogues and supportive peptides.
BPC-157, TB-500, and complementary compounds for connective tissue repair, training recovery, and sustained performance.
Epithalon, NAD+ adjuncts, and protocols targeting biological age reversal and cellular optimization.
Every protocol is physician-prescribed, lab-informed, and recalibrated quarterly as your biology evolves.
Submit your application. We review for fit, goals, and clinical eligibility within 48 hours.
Approved Founders complete intake and book their baseline lab draw at a partner facility.
A licensed clinician reviews your labs, history, and goals and prescribes a protocol tailored to your biology.
Compounded medications ship discreetly. Your care team activates.
Quarterly check-ins. Lab-driven adjustments. A care relationship that gets sharper over time.
Opus is the patient-facing membership of MyDose.ai. Every prescription is written by a licensed clinician. Every compound is dispensed exclusively by 503A compounding pharmacies — patient-specific, prescription-bound, and regulated by state boards of pharmacy. No research-grade vendors. No gray-market sourcing. Every protocol is documented, auditable, and recalibrated against your bloodwork.

The peptide chain at the heart of the Opus protocol.
The $497 secures your Founders seat and locks in lifetime $39/month pricing. It also includes your baseline lab panel (~$400 retail value). The fee goes into your care relationship — not marketing, not swag, not physical kits.
Founders pay $39/month for life. Standard Opus at launch will be $79/month. Founders also receive 15% lifetime product discount, $50/month product credit, priority clinical messaging, founders-only roundtables, and first-refusal access to new launches. Most of these perks are not offered at the standard tier.
No. Membership is the care relationship — physician access, lab interpretation, protocol design, and recalibration. Peptides, GLP-1s, and HRT are prescribed and purchased separately at member pricing. The $50/month product credit applies to all qualifying orders.
Three things. First, compliance: every compound dispensed exclusively by 503A compounding pharmacies — patient-specific, prescription-bound, state-board regulated. No research-grade vendors, no gray-market sourcing. Second, integration: peptides, GLP-1, and HRT under one care team, not three platforms. Third, intelligence: lab-driven protocol adjustments reviewed by your clinician quarterly — not stock protocols.
We integrate with your existing protocol. Bring your current bloodwork and prescriptions to onboarding. Your assigned clinician will determine whether to continue, adjust, or restructure based on your goals and clinical picture.
Opus operates in all 50 states through a network of licensed clinicians.
Within 48 hours. Founders applications are reviewed by the clinical team — this is not an instant checkout.
Lifetime pricing is locked for the life of an active membership only. Lapsed memberships do not retain the founders rate. You can pause for up to 90 days without losing your seat.
When 500 are filled, or when LegitScript certification clears and we move to public launch — whichever comes first. There is no second Founders cohort.
Founders are not customers. Founders are the cohort that shapes how Opus operates, what compounds we prioritize, and what care relationships look like as the industry matures. You're not signing up for a service. You're claiming a seat at the table.
Applications reviewed within 48 hours